Potential Treatment Target for Atherosclerosis Identified

Potential Treatment Target for Atherosclerosis Identified

by Chrisy Ngilneii on  June 13, 2018 at 7:13 PM Health Watch
RSS Email Print This Page Comment bookmark
Font : A-A+

Highlights:
  • A protective mechanism against atherosclerosis has been discovered.
  • The molecule B cell activating factor (BAFF) plays an important role in the development of atherosclerosis.
  • Deletion or blockade of the BAFF receptors reduces the development of atherosclerosis.
A potential target for future atherosclerosis treatments has been identified by a research team at the CEMM Research Center for Molecular Medicine of the Austrian Academy of Sciences.
Potential Treatment Target for Atherosclerosis Identified

The research team finds that deletion or blockade of the molecule BAFF receptors at the surface of B2 lymphocytes reduces the development of atherosclerosis in mice. BAFF is needed for the survival of a type of white blood cells called B2 lymphocytes which play an important role in the development of atherosclerosis.

With highly specific antibodies, BAFF can be bound and neutralized. Those antibodies where tested for their effects on the development of atherosclerosis in mice by scientists from CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna in collaboration with the University of Cambridge. The results were surprising: instead of reducing atherosclerotic lesion formation in the arteries of the tested mice, the antibody treatment lead to an increased plaque size.

"We were able to show that B2 lymphocytes were efficiently depleted upon anti-BAFF antibody treatment", senior author of the study Christoph Binder, CeMM Principal Investigator and Professor for Atherosclerosis Research at the Medical University of Vienna, describes the results of the study. "Surprisingly, the plaque size increased, indicating a hitherto unknown role of the BAFF molecule in atherosclerosis. However, in further experiments, we were able to explain these findings."

The researchers found BAFF to have anti-inflammatory properties, which has a positive effect on plaque size and atherosclerosis risk. The newly discovered mechanism is triggered by an alternative BAFF receptor - Transmembrane activator and CAML interactor (TACI) on the surface of macrophages, another type of immune cells. It was shown that these cells induce an anti-inflammatory process. This finding may provide important implications for atherosclerosis research and prevention: For example, mutations in the gene for TACI may confer an increased cardiovascular risk.

References:
  1. BAFF Neutralization Aggravates Atherosclerosis - ( http://circ.ahajournals.org/content/early/2018/05/31/CIRCULATIONAHA.117.032790)


  2. Source-Eurekalert
    Advertisement

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Cholesterol Heart Attack Cholesterol - The Enigma Chemical Atherosclerosis Aortic Dissection Renal Artery Stenosis Cholesteryl Ester Storage Disease Abdominal Aortic Aneurysm Atherectomy Carotid Endarterectomy 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...